Very long survival in pediatric cancer between 1944 and 1993

G Zhao1, C D Boysen, E F Brown

  • 1Henan Institute of Medical Sciences, Henan Medical University, Henan 450052, China.

Chinese Medical Journal
|October 17, 2001
PubMed

Insights

Pediatric cancer survival has significantly improved over four decades, with early diagnosis and later treatment eras leading to better outcomes. Patients surviving seven years post-diagnosis demonstrate excellent long-term survival rates.

Area of Science:

  • Pediatric Oncology
  • Cancer Epidemiology
  • Survival Analysis

Background:

  • Childhood and adolescent cancers present unique challenges in diagnosis and treatment.
  • Long-term survival in pediatric oncology is a critical indicator of treatment efficacy and evolving medical advancements.

Purpose of the Study:

  • To investigate factors associated with very long-term survival in pediatric cancer patients.
  • To analyze survival trends across different diagnostic categories and treatment eras.

Main Methods:

  • Retrospective analysis of 2750 pediatric cancer cases diagnosed between 1944 and 1983.
  • Categorization of cancers into 11 diagnostic groups and four distinct treatment eras.
  • Comparison of short-term (≤7 years) and long-term (>7 years) survival based on diagnostic and temporal factors.

Main Results:

  • Leukemias, CNS tumors, and Hodgkin's disease were the most prevalent cancer types.
  • Overall long-term survival rate was 41.7%, with significant increases observed from 18.7% in the earliest era to 52.6% in the latest.
  • Prognosis improved with earlier stage diagnosis and in later treatment eras, with statistically significant survival gains across most categories.

Conclusions:

  • Survival rates for pediatric and adolescent cancers have consistently improved over four consecutive eras.
  • Early diagnosis and advancements in diagnostic techniques are strongly correlated with better survival outcomes.
  • Pediatric cancer survivors often require long-term medical follow-up, highlighting the importance of sustained care beyond initial treatment.
Abstract

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...